Multiple studies have confirmed that CELF2 exerts tumour suppressive effects in most tumours, which is significantly increased in developing thymocytes and activated T cells, but its comprehensive understanding within the TME remains unknown.16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26. This evidence concerns the gene CELF2 and neoplasm.